Maintenance release for the writing app with a few bug fixes. ($5.99/$39.99 monthly/yearly subscription, free update, 63.3 MB, macOS 14+)

Introduces a new color picker and brings improved palette and window layouts. ($69.99 new, free update, 106.7 MB, macOS 10.13+)

Enables direct image editing in Pixelmator Pro for Apple Creator Studio subscribers. ($129.99 annual Apple Creator Studio subscription, various sizes, macOS 15.6+)

Apple Intelligence on-device processing remains Apple’s most convincing argument in artificial intelligence. Rivals may lead in public model rankings, chatbot adoption and the speed of releasing experimental features, but Apple is building AI inside devices people already use for their most personal work.

That distinction changes the definition of winning.

Apple does not need every iPhone owner to open a separate chatbot app. It can place intelligence inside Messages, Mail, Photos, Notes, Shortcuts, Siri and third-party apps. Local models can operate on private information without automatically transferring that information to an external server.

The strategy appeared slow while the AI market measured progress through chatbot launches and model size. It looks more competitive as the industry confronts cloud costs, privacy concerns, unreliable connectivity and the difficulty of turning general-purpose AI into useful daily actions.

In his video “Apple Lost the AI Race,” Marques Brownlee captures the contradiction in one concise line:

“Apple lost the AI race. Actually, Apple won the AI race.”

The apparent reversal describes Apple’s current position well. Apple may have lost the first race for public perception. It is increasingly prepared for the longer contest over where AI runs, how it reaches users and who controls the personal data required to make it useful.

Apple Intelligence On-Device Changes the AI Relationship

Most popular generative AI products began as cloud services. A user sends a request to a remote model, the provider processes it in a data center and the answer returns through an app or browser.

That structure supports enormous models but creates dependence on internet access, server capacity and continuing infrastructure expense. It also means personal prompts leave the device, even when the provider uses strong security and privacy policies.

Apple Intelligence on-device begins from the opposite direction. The iPhone, iPad or Mac first attempts to handle the request locally using Apple Foundation Models optimized for Apple silicon.

That local model does not need to know everything available on the internet. It needs to understand the user’s request, work with relevant personal context and complete common tasks efficiently.

The difference is similar to owning a capable computer rather than renting every calculation from a distant server. Cloud systems remain useful for difficult workloads, but they no longer need to participate in every interaction.

For Apple, local processing is also a product advantage. The company controls the chip, operating system, model architecture, memory system and apps. Each layer can be designed around the others rather than assembled from unrelated services.

Privacy Becomes a Technical Feature

Technology companies frequently describe privacy as a policy. Apple is trying to make it part of the AI architecture.

When a request runs entirely on an iPhone, the associated data does not need to leave the device. A model can work with messages, appointments, photos or app content without uploading that personal context to a conventional cloud account.

That structure is especially relevant to Siri AI. A truly personal assistant needs access to information that users may never place willingly inside an ordinary chatbot: private conversations, travel plans, health-related details, work documents and relationships between people.

An assistant becomes more useful as it gains context. It also becomes more invasive when the same context is stored, analyzed or used for model training outside the device.

Apple Intelligence on-device allows Apple to expand personal context while maintaining a stronger boundary around it. The assistant can understand information locally, perform an action and discard temporary processing data without building a permanent advertising or training profile.

This is difficult for competitors whose businesses depend on cloud services, large-scale data collection or engagement inside separate AI products. Apple’s hardware business gives it different incentives.

Private Cloud Compute Extends the Model

Not every AI task can fit within the power and memory limits of an iPhone. Apple uses Private Cloud Compute when a request requires a larger model.

Private Cloud Compute is designed to extend the privacy architecture of Apple devices into the cloud. User information is processed only for the request, is not stored and is not made available to Apple for unrelated purposes.

Independent researchers can inspect software images used by the system, creating an unusual level of outside visibility into the cloud environment. Apple has also expanded the architecture while maintaining control over the software and privacy protections used for processing.

This creates a layered system rather than a simple choice between local and cloud AI.

Apple Intelligence first determines whether the device can handle the request. More complex work can move to Private Cloud Compute. External models may be offered separately when the user chooses to involve them.

The user does not need to understand the technical path behind every answer. The system chooses the smallest and most private environment capable of completing the task.

Apple Silicon Was an AI Investment

Apple’s control of its processors has become one of its largest advantages in the AI era.

The Neural Engine first appeared years before generative AI became a consumer obsession. It supported Face ID, photography, speech recognition and other machine-learning tasks. Apple continued expanding that hardware across the iPhone, iPad and Mac.

Those investments now provide a large installed base of devices designed to run machine-learning workloads locally. Recent Apple chips combine CPU, GPU, Neural Engine and unified memory in one architecture that can move information efficiently between different types of processing.

The same design helps foundation models run without requiring the power consumption or separate memory systems associated with conventional data-center hardware.

Apple also controls the operating systems that schedule those workloads. A model can be optimized for the exact processors, memory limits and energy behavior of supported devices.

Competitors can build excellent models, but they often need to support hardware from several manufacturers with inconsistent capabilities. Apple can decide that an AI feature requires a specific generation of silicon and design the complete experience around it.

Developers Gain a Local Model

The Foundation Models framework extends Apple Intelligence on-device beyond Apple’s own apps. Developers can use the system model through native Swift tools rather than shipping a separate large model or paying for every cloud request.

An app can generate structured content, interpret natural language or use tool calling while keeping supported processing on the device. Apple handles model delivery and system integration.

This can reduce operating costs for developers. A cloud-based AI feature creates an ongoing expense each time a user submits a request. Local inference uses hardware the customer already owns.

It can also improve reliability. Features may remain available without an internet connection and respond without waiting for a remote service.

The framework encourages a quieter form of AI adoption. Apps do not need to add a prominent chatbot tab or redesign themselves around a conversational interface. Intelligence can appear inside existing workflows as a useful capability.

That is where Apple’s strategy may reach scale. Millions of apps can incorporate small AI functions that users experience as normal software behavior rather than as visits to an AI destination.

The Installed Base Is Apple’s Distribution Advantage

The AI race is often discussed as a contest between models. Consumer adoption also depends on distribution.

Apple can deliver new intelligence features through operating-system updates across the iPhone, iPad, Mac and Vision Pro. Users do not need to create another account, choose a provider or transfer their personal information into a new service.

Siri already occupies the system interface. Apple Intelligence can work across first-party apps. Developers can connect their own features through Apple frameworks.

The scale is difficult to reproduce. A model provider may have stronger benchmark scores but still need users to download an app and consciously open it. Apple can introduce AI during actions people already perform: replying to a message, locating a photo, organizing a note or completing a shortcut.

This does not guarantee success. Apple must make Siri AI reliable, keep feature availability consistent and prove that local models can deliver enough capability to satisfy users accustomed to powerful cloud assistants.

The distribution advantage only becomes meaningful when the experience works.

Winning Without Building the Loudest Chatbot

Apple has made mistakes during its AI transition. Siri improvements arrived later than promised, regional regulations delayed features and competitors established powerful consumer brands before Apple completed its new system.

Those setbacks explain why the claim that Apple lost the AI race became persuasive.

They do not settle the outcome.

The first stage rewarded companies that released chatbots quickly and demonstrated increasingly large models. The next stage may reward systems that can integrate AI into ordinary life without demanding constant cloud access, high subscription costs or broad collection of personal information.

Apple Intelligence on-device is built for that stage. It uses hardware already in the user’s hand, protects more personal context locally and gives developers access to intelligence without requiring every interaction to become a server transaction.

Apple does not need to win every benchmark or release the most talkative assistant. It needs AI to become a reliable part of the devices people already trust.

Brownlee’s title works because both statements can be true. Apple lost the visible sprint that defined the early generative AI market. By concentrating on local processing, silicon, privacy and operating-system integration, it may already be positioning itself to win the race that follows.

The post Apple Intelligence On-Device Is Winning the AI Race appeared first on AppleMagazine.

💾

Anthropic Bets on Deployment AI models keep getting better. What enterprises actually do with them is still an

Cadence Extends AI Agents Past Silicon Cadence introduced the AuraStack AI Super Agent on Wednesday, an agentic AI

Thinking Machines Ships Inkling Thinking Machines Lab released its first in-house model on Wednesday, and unlike the flagships

Japan Wires AI Into Medicine Japan built the world’s most trusted names in medical hardware and biopharma. This

Publishers Take Google to Court Over Gemini Three of the world’s largest publishers and a bestselling novelist filed

Many observations of solar flares suffer from saturation and blooming, causing crucial information to be lost. Researchers recently validated a technique for retrieving information from saturated flare images, unlocking a treasure trove of powerful solar flares for examination.

Solutions for Saturation

Since 2010, the Atmospheric Imaging Assembly (AIA) on the Solar Dynamics Observatory (SDO) has been capturing nearly continuous extreme-ultraviolet images of the Sun’s disk, revealing our star’s dramatic high-energy behavior. Though SDO/AIA’s observations have transformed our understanding of the Sun’s activity, they have limitations: powerful solar flares can saturate the detector, spilling charge into nearby pixels.

This saturation and overflow compromises our ability to study the most energetic solar flares — but the “lost” information may actually be recoverable. When light from an intense flare enters SDO’s instruments, not all of it pools in the saturated region of the detector: some of the light is diffracted by the optics, and by mathematically inverting this pattern of diffracted light, researchers can attempt to extract the encoded information about the saturated region. Researchers have used this technique for more than a decade, but options for validating the results were limited until now.

Solar Orbiter Lends a Hand

Launched almost 10 years to the day after SDO, the Solar Orbiter spacecraft provides an excellent opportunity to test inversion techniques for recovering information from saturated solar images. Solar Orbiter’s Extreme Ultraviolet Imager snaps brief photos of the Sun at a rapid cadence, and its images remain unsaturated even when faced with energetic solar flares.

As described in a recent research article by Sabrina Guastavino (University of Genoa; Italian National Institute for Astrophysics) and collaborators, the ideal setup for testing the inversion technique arose on 19 March 2024, when SDO and Solar Orbiter both viewed a solar flare while separated by just 1 degree in longitude.

Guastavino’s team aligned and reprojected the data, accounting for the slightly different viewing angles of the two spacecraft, then applied an algorithm called Adaptive SE-DESAT to reconstruct the flux within the saturated portion of the SDO image. The team compared the desaturated SDO images to the unsaturated Solar Orbiter images over the course of the flare, finding the same flare morphology and similar time evolution between the two data sets.

A Treasure Trove of Desaturated Data

Overall, these results demonstrate the effectiveness of the inversion technique, though Guastavino and coauthors noted that improvements could be made during the impulsive phase of the flare, when the emission is increasing. The team identified several reasons why the results may not match during this phase, including rapid evolution of the flare during individual exposures.

Despite these areas that require further attention, the validation of this technique unlocks 16 years of solar flare observations from SDO. This especially enhances our sample of powerful solar flares, increasing the available records of the most energetic solar flares by orders of magnitude.

Citation

“Validation of an Extreme-Ultraviolet Desaturation Technique for the Atmospheric Imaging Assembly on Board the Solar Dynamics Observatory Using Observations from the Extreme Ultraviolet Imager on Board Solar Orbiter,” Sabrina Guastavino et al 2026 ApJL 1005 L50. doi:10.3847/2041-8213/ae7d2e

The post When the Spacecraft Align: Rescuing Saturated Images of Solar Flares appeared first on AAS Nova.

Neuroscientists have long believed that language processing was only found in regions of the brain’s left hemisphere, including the well-known Broca’s area. However, new evidence suggests the brain’s language network is far more widespread than previously thought. 

Researchers at the Massachusetts Institute of Technology (MIT) analyzed functional magnetic resonance imaging (fMRI) scans from 772 participants and identified 17 additional brain regions involved in language comprehension. These newly discovered areas are distributed across the brain, including the cerebellum, hippocampus, amygdala, and several regions of the cerebral cortex. In total, this accounts for five percent of the adult brain volume (roughly the size of a large strawberry). 

“Even though there are all these distant components, it’s pretty restricted in terms of volume. You don’t need that much of the brain to do language,” says senior author Evelina Fedorenko, an MIT associate professor of brain and cognitive sciences and a member of MIT’s McGovern Institute for Brain Research, in a statement. 

Locating the Brain’s Hidden Language Centers

To find these hidden language-related regions in the brain, the researchers revisited years of brain imaging data collected since 2013. Additionally, participants completed a standard “language localizer” task, during which they read or listened to meaningful sentences and sequences of meaningless nonwords. By comparing brain activity between these two conditions, the research team identified regions that responded more strongly to language.

“When we initially started looking at language, in the first couple of papers, I tried to be comprehensive and include anything that seemed consistent across participants, and there was a huge amount of resistance,” said Fedorenko. “People would say things like, ‘Well, we know those are not language areas, so please focus on the language areas.’”

The team decided to adopt a more flexible statistical approach to detect weaker signals and identify previously overlooked language-sensitive regions beyond the classical language areas. They then compared these regions’ responses during a spatial working memory task to distinguish language-specific areas from those involved in what would be considered general cognitive functions.

Cerebellum Discoveries

Interestingly, five of the newly identified language regions are located in the cerebellum, a structure traditionally associated with movement and coordination. Some of these cerebellar regions were also active during non-language tasks, suggesting they may help integrate information across different brain systems rather than process language alone.

“It’s a very simple paradigm that lets you identify this core language system in individual brains,” says MIT postdoc Agata Wolna, the lead author of the paper.

Additional language-sensitive regions were identified in the hippocampus and amygdala, areas better known for their roles in memory and emotion. Their involvement suggests that understanding language may rely more on integrating memory, emotional context, and higher-order cognitive functions than previously understood in science.

“We always see this frontal temporal network, but there’s quite a lot of evidence that there are other regions that are also critical for language processing,” said Wolna. “By using a laxer threshold and zooming in on areas with weak MRI signal, we tried to maximize the chances of finding small and weakly responsive regions outside of this left frontal temporal system.”

The findings challenge long-held assumptions about the brain’s organization and can open new avenues for research into how language processing is understood in neuroscience.

The recent study was published in the Journal of Neuroscience. 

Chrissy Newton is a PR professional and the founder of VOCAB Communications. She currently appears on The Discovery Channel and Max and hosts the Rebelliously Curious podcast, which can be found on YouTube and on all audio podcast streaming platforms. Follow her on X: @ChrissyNewton, Instagram: @BeingChrissyNewton, and chrissynewton.com. To contact Chrissy with a story, please email chrissy @ thedebrief.org.

Enzymes and other biomolecules are often anchored onto solid materials so they can be reused, purified more easily, and made more stable, a strategy biotechnology has relied on since industrial-scale immobilized enzymes first appeared in chemical manufacturing in the mid-twentieth century. Immobilized enzymes today drive processes from food and pharmaceutical production to biosensors and medical diagnostics. Fixing a biomolecule in place, however, is not as simple as gluing it down. The exact spot where it attaches, the direction it faces, and how much freedom it retains to move can all change how well it works. Testing every possible arrangement in the laboratory is slow and costly, which is why computer simulation has become such a valuable complement to experiments.

The Martini force field

One of the main tools for this kind of study is molecular dynamics simulation, which calculates how atoms move over time by applying the basic laws of physics. Simulating every single atom of a protein, its surrounding water, and a supporting material gives rich detail, but is extremely demanding on computing power, especially when many attachment geometries need comparing. A widely used shortcut is coarse-grained modeling, in which small clusters of atoms are grouped into single, simplified particles. This keeps the essential physical behavior of the system while making the calculations far cheaper. The most established coarse-grained approach for biological molecules is the Martini force field, first developed in 2004 to describe fatty, membrane-forming molecules and later extended to proteins and, more recently, to a more accurate third generation of the model. Martini has since become a standard tool for simulating large biological assemblies that would otherwise be out of reach.

Introducing MartiniSurf

A team of researchers now introduces MartiniSurf ¹, an open-source software package that automates the preparation of these coarse-grained simulations for biomolecules attached to surfaces. Building such a system by hand normally involves several separate programs and many manual steps, which makes it hard to reproduce results or compare different setups fairly. MartiniSurf instead combines the whole process into a single, streamlined workflow. Starting from the structure of a protein or a DNA strand, it converts the molecule into its coarse-grained form, builds a model of the supporting surface, positions the molecule in a chosen orientation, adds water and dissolved ions, and produces all the files needed to run the simulation with GROMACS, a molecular dynamics program that has been developed and refined for decades. Because every step is controlled by explicit settings rather than manual adjustments, two researchers using the same settings should obtain the same starting system, making comparisons across studies far more reliable.

Restraining forces or linkers

A central feature of the software is its flexibility in representing how a biomolecule is attached. In one mode, selected regions of the molecule are held near the surface through simple restraining forces, without modeling the physical connector itself. In another mode, an explicit molecular linker is placed between the biomolecule and the surface, so that the linker’s own length and flexibility can influence the simulation. Because the properties of such linkers are known to affect how active and stable an attached enzyme remains, this second option offers a more realistic picture whenever the necessary coarse-grained description of the linker is available.

Variety of supporting surfaces

The supporting surfaces themselves can also be varied widely. The software can generate simple flat reference surfaces or draw on previously developed coarse-grained models of real materials such as graphene, graphite, carbon nanotubes, and agarose-like gels, the type of porous material commonly used to immobilize enzymes in the laboratory. Properties such as surface chemistry, electric charge, particle spacing, and added chemical groups can all be adjusted. Recent studies have shown that surfaces built without care can cause water molecules near the interface to line up in unrealistic, almost frozen patterns, an artifact rather than genuine physical behavior. The software includes options that let users introduce controlled irregularity into the surface to reduce this problem, while staying consistent with the wider Martini modeling framework.

In practice

To demonstrate how the approach works in practice, the study presents examples involving both proteins and DNA. For an enzyme attached to an agarose-like surface, the software reproduces several different attachment arrangements, including a complete system containing the enzyme together with its natural helper molecule and reaction substrate. These examples show how changing the attachment point or adding chemical groups to the surface can be explored systematically, without needing to reconstruct every model from scratch by hand.

The approach is also extended to DNA tethered to a graphene-like surface, comparing an electrically neutral surface with a positively charged one. The coarse-grained simulations reproduce the same general behavior previously reported in much more computationally demanding all-atom studies: the DNA strand remains mostly upright above the neutral surface but bends progressively toward the surface when it carries a positive charge, drawn in by electrostatic attraction. This comparison is not meant to reproduce exact experimental values, but rather to confirm that the automated setup captures the right physical trends, providing a check on the reliability of the workflow.

Reproducibility

Every simulation generated by the software automatically records the settings, software versions, and modeling choices used to build it, so that another researcher can repeat or directly compare a given calculation later. Importantly, the software does not introduce new physical models or new force-field parameters of its own. Instead, it draws on already validated Martini tools and organizes them into a consistent, automated pipeline.

Overall, MartiniSurf addresses a practical bottleneck in computational chemistry rather than proposing a new simulation method. By automating the construction of surface-bound protein and DNA systems, it makes coarse-grained molecular dynamics studies faster to set up, easier to reproduce, and simpler to scale across many attachment geometries. This kind of tool should make it easier to systematically study how surface properties, attachment geometry, and molecular flexibility shape the behavior of immobilized biomolecules, supporting the design of better catalysts, biosensors, and other biotechnology applications.

Author: César Tomé López is a science writer and the editor of Mapping Ignorance

Disclaimer: Parts of this article may have been copied verbatim or almost verbatim from the referenced research paper/s.

The post Overcoming bottlenecks in bio-interface simulations: The MartiniSurf Approach appeared first on Mapping Ignorance.

Have you ever said “thanks” to ChatGPT, or “please” to Claude? Maybe you’re just being polite, showing some

Help Yes, Robot Romance No Match Group wanted to know how American singles feel about artificial intelligence creeping

If you shop on Google Flights, you get a quick comparison for different itineraries: One flight’s carbon emissions

In an era where environmental pollutants increasingly threaten public health, breakthrough scientific methodologies are emerging to decipher the complex puzzle of chemical exposures in everyday life. The U.S. Environmental Protection Agency (EPA), through its innovative Exposure Forecasting (ExpoCast) project, has unveiled a suite of high-throughput novel approaches that promise to revolutionize our understanding of human exposure to hazardous substances. These new approach methodologies integrate cutting-edge computational power, biomonitoring data, and machine learning to clarify how chemicals enter and navigate the human body via different exposure pathways.

At the core of this scientific leap is the urgent need to move beyond traditional, labor-intensive measures of exposure assessment. Conventional methods, reliant on direct environmental sampling or biomarker tracking alone, often provide fragmented or delayed insights. ExpoCast’s high-throughput frameworks address this by enabling the rapid processing of vast chemical datasets and synthesizing multifaceted exposure routes—dermal contact, inhalation, and ingestion—into cohesive predictive models. This integration forms the backbone of a new era in toxicological science, one that could empower preventive public health strategies with unprecedented accuracy and speed.

The advanced computational techniques deployed in this research pivot on two pivotal innovations. First, the ability to infer chemical intake directly from metabolite measurements represents a quantum leap in exposure science. Metabolites—the biochemical footprints left by toxicants within the body—offer a window into the internal chemical burden of an individual. This invertible analytic approach not only isolates the true extent of chemical accumulation but also contextualizes it within the dynamic processes of metabolism and excretion. Such resolution provides critical clues for both risk characterization and regulatory evaluation.

Complementing this metabolite-centric analysis are high-throughput models that simulate multi-pathway exposures. Unlike prior assessments that treated exposure routes in isolation, these models encapsulate the reality of simultaneous, overlapping chemical encounters encountered in everyday environments. By integrating data across air, dust, water, and dietary matrices, the models generate comprehensive exposure profiles that reflect the true cumulative burden experienced by populations. This holistic perspective marks a paradigm shift in exposure science, with far-reaching implications for epidemiological research and environmental policy.

Another cornerstone of the ExpoCast project’s success lies in its deployment of sophisticated machine learning (ML) algorithms to bridge pervasive data gaps. Chemical exposure data are notoriously incomplete, especially for emerging contaminants and complex mixtures. The machine learning methods exploit chemical structures and existing information repositories to predict missing values, refine exposure estimates, and identify likely high-exposure scenarios. Through these predictive analytics, the EPA’s approach dramatically enhances the resolution and reliability of exposure assessments without the untenable demands of large-scale physical sampling.

The strength of coupling high-throughput analytics with ML-based data gap filling is evident in a recently published case study application that specifically targets indoor environments. Indoor settings are recognized as critical exposure venues given the amount of time individuals spend inside homes, workplaces, and public buildings. In this case study, researchers synchronized biomarker findings from human subjects with media-specific chemical concentration measurements—dust, indoor air, and surface residues—to validate the accuracy and applicability of their models. The congruence observed underscores the potential of these next-generation methodologies to accurately capture exposure nuances in real-world scenarios.

Delving into the technicalities, the approach of inferring chemical intake from biomarker data involves mechanistic, pharmacokinetic models. These models simulate the absorption, distribution, metabolism, and elimination (ADME) of chemicals, allowing reverse calculation from measured metabolite concentrations back to estimated exposure doses. Integrating population variability and uncertainty quantification within these models further refines predictions, supporting more nuanced risk assessments that reflect real human diversity and exposure complexities.

High-throughput exposure models, meanwhile, employ automated workflows powered by large chemical libraries, exposure factor databases, and physiological parameters. These workflows rapidly generate exposure estimates across thousands of chemicals and scenarios, facilitating prioritization in regulatory contexts. The incorporation of multi-pathway assessments elevates these models beyond simple single-route frameworks, capturing interactive effects such as dermal absorption following inhaled volatilization, or ingestion arising from hand-to-mouth transfer of settled dust.

Machine learning strategies, spanning supervised and unsupervised techniques, utilize features derived from chemical structure descriptors, physicochemical properties, and known exposure pathways to fill data voids. These models can predict exposure likelihood, magnitude, and temporal patterns with quantifiable confidence. Importantly, the EPA team employed interpretability-focused ML algorithms to ensure that the models’ decision-making processes remain transparent to toxicologists and risk assessors, a critical factor for regulatory acceptance and scientific scrutiny.

Together, these novel methodologies embody a systems-level approach to understanding chemical exposures that integrates biological, environmental, and computational sciences. They represent a shift from descriptive monitoring to predictive and mechanistically informed exposure science, capable of anticipating emerging public health threats before widespread harm occurs. Such anticipatory capacity aligns with modern needs for proactive environmental health management amid ever-expanding chemical use.

The implications extend beyond academia or regulatory agencies. Public health practitioners, clinicians, and community advocates can leverage these insights to better understand exposure disparities, tailor interventions, and inform vulnerable populations. For instance, accurately predicting exposure levels in indoor environments helps prioritize remediation or behavior modification strategies for those disproportionately impacted by chemical pollutants, such as children or individuals in lower socioeconomic strata.

From an innovation standpoint, the ExpoCast project exemplifies the power of integrating novel in silico tools with empirical biomonitoring, fostering a virtuous cycle of model refinement and real-world validation. This iterative process ensures that computational predictions remain grounded in biological realities, enhancing confidence in exposure and risk evaluations. Furthermore, as chemical inventories expand and new compounds emerge, these scalable, automated methodologies will be indispensable for keeping pace with the evolving regulatory landscape.

The broader environmental science community stands to benefit from adopting similar high-throughput, machine-learning-enabled approaches. The generalizability of these methodologies means they can be adapted for global chemical monitoring programs, occupational health assessments, and ecosystem exposure analyses. Cross-disciplinary collaboration will be critical to extend these tools and harmonize data frameworks, advancing a unified, internationally coordinated approach to chemical safety.

In conclusion, the EPA’s ExpoCast-driven advancements represent a milestone in exposure science, knitting together innovative analytical methods to unravel the complexities of human-chemical interactions. By harnessing metabolite-informed intake reconstruction, multi-pathway exposure modeling, and machine learning-based data gap filling, the project paves the way for more accurate, timely, and insightful exposure assessments. This transformative toolkit holds promise to enhance chemical risk management, protect public health, and guide sustainable environmental stewardship in an increasingly chemical-dependent world.

The research outlined in the recent publication epitomizes the potential of high-throughput new approach methodologies to revolutionize exposure science across diverse settings—from homes and workplaces to broader communities. Continued development, validation, and deployment of such integrative frameworks will be paramount in confronting the escalating challenges posed by chemical exposures in the 21st century.

---

Subject of Research:
Development and application of high-throughput new approach methodologies for complex chemical exposure assessment, involving biomarker inference, multi-pathway exposure modeling, and machine learning-driven data gap filling.

Article Title:
Case study application of high-throughput new approach methodologies for exposure to the interpretation of matched biomarker and indoor media measurements.

Article References:
Jacketti, M.A., Biryol, D., Setzer, R.W. et al. Case study application of high-throughput new approach methodologies for exposure to the interpretation of matched biomarker and indoor media measurements. J Expo Sci Environ Epidemiol (2026). https://doi.org/10.1038/s41370-026-00926-y

Image Credits: AI Generated

DOI: 21 June 2026

In a groundbreaking study soon to redefine neuroscientific understanding of memory mechanisms, researchers have uncovered the pivotal role played by Neurensin-2 (NRSN2) in regulating hippocampal synaptic plasticity and memory functionality. This newly published research reveals how deficiency in NRSN2 leads to profound impairments in memory, traced back to disrupted excitatory synaptic transmission and weakened long-term potentiation (LTP) within the hippocampus, a brain region critically involved in memory formation and cognitive processing.

The hippocampus serves as the brain’s memory hub, integrating myriad neuronal signals to encode and retrieve information efficiently. Central to this integration is the function of excitatory synapses that employ glutamate receptors, especially the N-methyl-D-aspartate (NMDA) receptor, which plays an essential role in synaptic plasticity—the ability of synapses to strengthen or weaken over time. This plasticity underlies learning and memory. The study elucidates how NRSN2 exerts a regulatory influence on the expression of NMDA receptor subunits, with deficiency in NRSN2 tipping the balance unfavorably and compromising synaptic efficacy.

Utilizing advanced genetic models, the investigators engineered mice lacking NRSN2 to dissect its functional contributions. Behavioral assays showcased a marked decline in memory performance, particularly in spatial and recognition tasks reliant on hippocampal circuits. These deficits were not attributed to developmental anomalies but to disrupted synaptic physiology, signaling a direct role for NRSN2 in maintaining synaptic integrity and plasticity during adult cognition.

At the molecular scale, the absence of NRSN2 triggered a significant downregulation of key NMDA receptor subunits, notably NR1, NR2A, and NR2B. These subunits orchestrate receptor assembly and gating properties critical for calcium influx, a signal cascade necessary for potentiation of synaptic strength. The reduction in their expression correlated tightly with the inhibition of LTP induction, a process considered the cellular analog of memory encoding, confirming the hypothesis that NRSN2 deficiency impairs memory by hampering core synaptic mechanisms.

Electrophysiological recordings from hippocampal slices further substantiated the disrupted synaptic function. In control animals, robust LTP was readily induced by theta burst stimulation—a protocol mimicking physiological neuronal firing during learning. Conversely, hippocampi from NRSN2-deficient mice exhibited significantly weakened potentiation, underscoring the protein’s critical role in modulating synaptic responsiveness. This impairment was not a general defect of synaptic transmission but selectively impacted excitatory plasticity mediated through NMDA receptors.

Delving deeper, the team explored the intracellular cascades influenced by NRSN2, discovering that its absence perturbed the trafficking and surface expression of NMDA receptor complexes. NRSN2 appears to act as a chaperone or scaffold protein, ensuring proper receptor assembly and synaptic localization. Without it, receptor subunits fail to achieve adequate membrane insertion, resulting in diminished postsynaptic sensitivity to glutamate and compromised signal transduction.

This mechanistic insight offers a fresh perspective on how synaptic architecture and molecular composition govern cognition. The study’s integration of molecular biology, electrophysiology, and behavioral neuroscience draws a comprehensive picture of how a single protein’s deficit can destabilize the neural substrates of memory. Such findings not only enrich fundamental neuroscience but also hint at novel targets for cognitive-enhancing therapies.

Intriguingly, alterations in NRSN2 expression and NMDA receptor dysfunction have been implicated in various neuropsychiatric disorders, including schizophrenia and major depressive disorder. By illuminating this molecular nexus within the hippocampus, the research opens doors to understanding disease pathophysiology at a finer scale and may spur development of precision interventions aimed at restoring synaptic balance in affected individuals.

The investigators also examined compensatory mechanisms that might mitigate NRSN2 absence. While some plasticity-related proteins showed upregulation, these changes failed to rescue the deficits in NMDA receptor expression and synaptic potentiation. This highlights the non-redundant and indispensable nature of NRSN2 in maintaining synaptic homeostasis and cognitive function.

Beyond the laboratory findings, the study raises fascinating questions about how synaptic proteins coordinate to sustain the dynamic range of neural connectivity required for adaptive learning. The delicate equilibrium modulated by NRSN2 and NMDA receptors underscores the complexity of neuronal networks and their vulnerability when key molecular elements are compromised—insights that are pivotal as the field seeks to decode the neural basis of memory disorders.

Future research directions spawned by this work include investigating how NRSN2 interacts with other synaptic scaffold proteins and cytoskeletal elements, potentially shaping the three-dimensional organization of the postsynaptic density. Additionally, exploring the developmental timeline of NRSN2 expression could reveal critical periods during which intervention might prevent or reverse memory impairments.

From a translational perspective, the study’s revelations beckon the clinical neuroscience community to consider NRSN2 and its pathways as therapeutic candidates. Pharmacological strategies aimed at upregulating NRSN2 or mimicking its stabilizing effects on NMDA receptors could hold promise for enhancing cognition or slowing neurodegenerative progression in disorders marked by synaptic decline.

In sum, this landmark research defines NRSN2 as a vital regulator of excitatory synaptic plasticity and memory formation. Its deficiency causes a cascade of molecular disturbances culminating in impaired NMDA receptor expression and disrupted LTP, ultimately compromising hippocampal-dependent memory functions. This work not only advances our understanding of the molecular machinery underlying memory but also charts new territory in the quest to ameliorate cognitive dysfunction.

As neuroscience inches closer to mapping the intricate cellular and molecular landscape of cognition, findings such as these underscore the profound impact a single synaptic protein can have on brain function. The compelling evidence presented lays a robust foundation for future explorations into synaptic plasticity and memory, promising strides in both basic science and clinical applications that may soon transform lives burdened by memory loss.

---

Subject of Research: Impact of Neurensin-2 (NRSN2) deficiency on hippocampal memory functions and synaptic plasticity

Article Title: Impact of NRSN2 deficiency on memory: Altered excitatory synaptic plasticity associated with reduced expression of NMDA receptor subunits and impaired LTP in the hippocampus.

Article References:
Wei, J., Wu, Y., Yi, Y. et al. Impact of NRSN2 deficiency on memory: Altered excitatory synaptic plasticity associated with reduced expression of NMDA receptor subunits and impaired LTP in the hippocampus. Transl Psychiatry (2026). https://doi.org/10.1038/s41398-026-04163-7

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41398-026-04163-7

Norway Pulls AI From Grade School Norway is placing tight limits on generative AI across its schools. Prime

In a groundbreaking departure from traditional approaches, researchers have unveiled a transformative perspective on EEG biomarkers for brain disorders, emphasizing a transdiagnostic dimensional framework that promises to revolutionize neuropsychiatric diagnostics and treatment. This pioneering study, conducted by Zebhauser, Heitmann, Henningsen, and colleagues, challenges decades-old conventions that pigeonhole brain disorders strictly according to categorical diagnostic criteria. Instead, it advocates for a more nuanced, continuum-based understanding of brain dysfunctions as reflected in electroencephalographic signals.

The conventional paradigm in neuropsychiatry has long relied upon discrete diagnostic labels—labels which often fall short in capturing the complex, overlapping symptomology exhibited across disorders such as schizophrenia, bipolar disorder, major depressive disorder, and anxiety disorders. Traditional EEG analyses have sought biomarkers confined within these diagnostic categories, leading to inconsistent results and limited clinical utility. The new study confronts these limitations by proposing that EEG biomarkers be analyzed through a dimensional lens that transcends categorical boundaries, enabling detection of underlying neural dysfunctions that span multiple disorders.

Central to this conceptual shift is the transdiagnostic approach, which posits that neurobiological aberrations are shared across different psychiatric conditions and manifest along spectrums of symptom severity and cognitive impairment. Through rigorous computational modeling and advanced signal processing applied to large EEG datasets, the research team delineated patterns of neural oscillatory activity and connectivity that correlate with continuous measures of cognitive and affective dysfunctions, irrespective of diagnostic categories. This approach underscores the shared neurophysiological substrates that traditional categorical classifications often obscure.

Methodologically, the study harnessed sophisticated machine learning algorithms to parse high-dimensional EEG data and extract signal features indicative of brain circuit dysregulation. By focusing on spectral power variations across frequency bands—delta, theta, alpha, beta, and gamma—as well as functional connectivity metrics between cortical networks, the researchers succeeded in identifying biomarkers reflective of symptom dimensions such as cognitive control deficits, emotional dysregulation, and sensory processing anomalies. These dimensions overlap across disorders, suggesting a common pathophysiological mechanism modulated along a continuum.

Importantly, the transdiagnostic dimensional framework enables more personalized and precise characterization of patients’ neural profiles. Instead of forcing diagnoses into rigid boxes, clinicians can now utilize EEG biomarkers to quantify an individual’s specific symptom constellation and severity in real-time. This precision facilitates tailored interventions that target dysfunctional brain networks directly, potentially enhancing treatment efficacy and reducing trial-and-error prescribing that often plagues psychiatric care.

The implications extend beyond diagnosis and treatment optimization. This novel EEG biomarker approach offers a powerful tool for preventative psychiatry by identifying at-risk individuals who may not yet meet full diagnostic criteria but exhibit measurable neural dysfunctions indicative of emerging disorders. By mapping these dimensional brain signatures early, clinicians can intervene preemptively, possibly altering disease trajectories before chronicity sets in.

Moreover, this paradigm fosters an integrative understanding of brain disorders as dynamic states rather than static labels. The EEG biomarkers track fluctuation in cognitive and affective states, capturing the temporal evolution of illness and response to therapy. Such temporally sensitive biomarkers pave the way for real-time monitoring of treatment response and disease progression via non-invasive methods, enhancing clinical decision-making and patient outcomes.

The study also confronts several technical challenges historically hindering EEG’s clinical translation. By developing robust preprocessing pipelines that mitigate artifacts and employing cross-validation techniques to ensure replicability of findings across diverse cohorts, the researchers set new standards for EEG research rigor. Their comprehensive methodology serves as a blueprint for future investigations aiming to unify neurophysiological data with psychiatric phenotypes in a clinically meaningful manner.

Furthermore, by adopting a transdiagnostic dimensional view, the research opens novel avenues for drug development. Pharmaceutical interventions can be engineered to target neural circuits and pathways implicated across multiple disorders, possibly leading to broader spectrum therapeutics with enhanced efficacy. This contrasts with the current trend of developing highly disorder-specific drugs, which may only benefit a subset of patients.

Underpinning this research is the recognition that brain disorders are multifactorial and multifaceted, involving intricate interactions between genetics, environment, and neural circuitry. The EEG biomarkers illuminated by this study reflect emergent properties of large-scale brain networks whose dysfunction cuts across traditional diagnostic divides. This holistic lens aligns with contemporary theories of brain function as distributed and dynamic, rather than localized and static.

Clinically, the transdiagnostic dimensional EEG biomarkers facilitate identification of subtypes within disorders, based on distinct neurophysiological profiles. Such stratification could improve prognostic accuracy and enable stratified clinical trials, ultimately accelerating discovery and application of targeted therapies. This personalized medicine approach marks a considerable leap in the field of psychiatry.

The study’s findings also resonate deeply with the Research Domain Criteria (RDoC) initiative advocated by the National Institute of Mental Health, which promotes research centered on fundamental dimensions of functioning rather than syndromic categories. The demonstrated EEG biomarkers provide tangible neurobiological correlates for RDoC constructs such as cognitive systems and arousal/regulatory systems, making a compelling case for their adoption in clinical and research frameworks.

Ethical and practical considerations emerge as these new EEG biomarkers are integrated into clinical practice. Ensuring equitable access to advanced neurodiagnostic technologies and protecting patient privacy with respect to neural data will be paramount. The authors acknowledge these issues and call for development of guidelines and safeguards alongside technological progress to maximize benefit and minimize harm.

This research heralds a new era in neuropsychiatry, where neural biomarkers derived from accessible EEG recordings become central to understanding, diagnosing, and treating brain disorders as dimensional phenomena. By transcending rigid diagnostic boundaries, this approach reflects the complex reality of brain function and dysfunction, offering hope for more effective, individualized care for millions worldwide impacted by mental illness.

In conclusion, the visionary framework proposed by Zebhauser and colleagues challenges entrenched conventions and illuminates a path forward marked by dimensional precision, cross-disorder integration, and clinically actionable EEG biomarkers. This work stands to reshape the landscape of psychiatric neuroscience and catalyze a shift toward truly personalized mental health care.

---

Subject of Research: EEG biomarkers and their application in a transdiagnostic dimensional framework for brain disorders

Article Title: Rethinking EEG biomarkers of brain disorders: a transdiagnostic dimensional view

Article References: Zebhauser, P.T., Heitmann, H., Henningsen, P. et al. Rethinking EEG biomarkers of brain disorders: a transdiagnostic dimensional view. Transl Psychiatry 16, 316 (2026). https://doi.org/10.1038/s41398-026-04187-z

Image Credits: AI Generated

DOI: 10 June 2026

Researchers built Sashimi-Bot to master one of robotics’ slipperiest challenges.